Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/1/2025

Weight Effects of Antidepressants

Comparison with Other Antidepressants

  • The American Gastroenterological Association notes that among antidepressants, bupropion is the only agent consistently associated with weight loss, while mirtazapine and paroxetine are associated with greater weight gain 1, 2, 3
  • The American Gastroenterological Association recommends considering the antidepressant hierarchy of weight gain risk, with mirtazapine, paroxetine, and amitriptyline having the highest risk, and fluoxetine and sertraline having a neutral or minimal risk 1, 2

Monitoring and Management Considerations

  • The American Gastroenterological Association suggests that for patients with pre-existing weight concerns or obesity, consider the relative weight effects when selecting an antidepressant, with bupropion potentially being a more favorable option if clinically appropriate for the patient's specific depression presentation 1, 2, 3

Common Pitfalls and Caveats

  • The American Gastroenterological Association notes that weight changes with antidepressants are often multifactorial and may be influenced by improvement in depression symptoms, lifestyle changes, and other medications 1, 3

Weight Profile of Venlafaxine

Comparative Weight Effects

  • Mirtazapine and paroxetine resulted in significantly higher weight gain than venlafaxine in head-to-head comparisons 4, 5, 6
  • Nausea and vomiting are common side effects of venlafaxine, which may contribute to weight loss rather than gain 4, 5, 6

Mechanism and Associated Symptoms

  • Venlafaxine's SNRI mechanism appears to promote decreased appetite rather than increased appetite 7
  • The most commonly reported side effects of venlafaxine are nausea and vomiting, which may contribute to weight loss rather than gain 4, 5, 6

Clinical Implications

  • Avoid mirtazapine and paroxetine in weight-sensitive patients as they carry the highest risk of weight gain 4, 5, 6